Skip to main content
Equibles

ROYCE & ASSOCIATES LP

Position in HAE — Haemonetics Corp

CIK 906304 New York, NY
Back to HAE Full portfolio

Position in HAE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,360,625
+$1,332,294 QoQ
Shares Held
71,475
0.0% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#67
of 329 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HAE Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

ROYCE & ASSOCIATES LP holds $200,471,862 across 21 Medical Devices names. HAE ranks #14 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ESTA
Establishment Labs Holdings Inc.
 472,316 $40,529,435
2 BVS
Bioventus Inc.
 1,833,212 $17,305,521
3 APYX
Apyx Medical Corp
 3,274,064 $14,700,547
4 AORT
Artivion, Inc.
 639,282 $14,364,666
5 ENOV
Enovis CORP
 662,183 $13,707,188
6 TNDM
Tandem Diabetes Care Inc
 900,590 $13,589,903
7 UFPT
Ufp Technologies Inc
 44,465 $11,789,005
8 CBLL
Ceribell, Inc.
 605,010 $11,767,444

All Filings in HAE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,360,625 71,475
2026-03-31 $4,028,331 71,475
2025-12-31 $5,728,721 71,475
2025-09-30 $34,178,535 701,242
2025-06-30 $94,833,562 1,271,057
2025-03-31 $73,800,360 1,161,296
2024-12-31 $90,047,165 1,153,268
2024-09-30 $97,303,687 1,210,546
2024-06-30 $97,594,760 1,179,678
2024-03-31 $108,105,504 1,266,614
2023-12-31 $82,633,016 966,355
2023-09-30 $84,881,529 947,550
2023-06-30 $77,161,700 906,292
2023-03-31 $69,820,643 843,754
2022-12-31 $64,922,586 825,462
2022-09-30 $64,762,036 874,808
2022-06-30 $54,854,510 841,585
2022-03-31 $47,872,965 757,244
2021-12-31 $37,558,048 708,108
2021-09-30 $69,485,831 984,358
2021-06-30 $40,087,025 601,546
2021-03-31 $52,017,620 468,585
2020-12-31 $71,102,275 598,756
2020-09-30 $50,919,798 583,608
2020-06-30 $44,170,365 493,193
2020-03-31 $37,532,454 376,605